Skip to content
★ Sign in to follow
RW

Robert W. Pangia

Biogen Inc.Icos CorpMcAfee, Inc.
Total declarations
160
Companies
3
▲ Purchases (0 ops.)
—
▼ Sales (101 ops.)
€24.3M

Latest filing published 05 Jun 2020 for BIOGEN INC..

Filing timeline

BuySale
Robert W. Pangia

Insider track record

Disclosed buys
0
Disclosed sells
101
Signal history

Robert W. Pangia: trading record in brief

Robert W. Pangia has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Biogen Inc., McAfee, Inc. and Icos Corp. We count 160 filings; the first trade dates from 19 September 2005 and the latest from 3 June 2020.

No open-market purchase appears, only 101 sales worth €24.3M. Outside the open market, there are 17 share grants and 35 option exercises.

The newest entry dates from 5 June 2020: a share grant, in Biogen Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Robert W. Pangia

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations145 total
  • ◆
    DirectorExecutivesBiogen Inc.
    0SEC
    890 shares0Common StockSEC:0001127602-20-019029:0
  • ◆
    DirectorExecutivesBiogen Inc.
    0SEC
    1,155 shares0Common StockSEC:0001127602-19-022422:0
  • ◇
    DirectorExecutivesBiogen Inc.
    319,273 USD12SEC
    6,114 shares@ US$52.227.2% of flowCommon StockSEC:0001127602-19-012198:0
  • ▼
    DirectorExecutivesBiogen Inc.
    2M USD15SEC
    6,114 shares@ US$328.5545.0% of flowCommon StockSEC:0001127602-19-012198:1
  • ◆
    DirectorExecutivesBiogen Inc.
    0SEC
    880 shares0Common StockSEC:0001127602-18-020966:0
  • ◇
    DirectorExecutivesBiogen Inc.
    337,265 USD11SEC
    5,832 shares@ US$57.834.9% of flowCommon StockSEC:0001127602-18-001563:0
  • ▼
    DirectorExecutivesBiogen Inc.
    2M USD14SEC
    5,832 shares@ US$329.6528.0% of flowCommon StockSEC:0001127602-18-001563:1
  • ◆
    DirectorExecutivesBiogen Inc.
    0SEC
    1,055 shares0Common StockSEC:0001127602-17-021098:0
  • ◇
    DirectorExecutivesBiogen Inc.
    284,599 USD11SEC
    5,450 shares@ US$52.224.7% of flowCommon StockSEC:0001127602-17-001434:0
  • ▼
    DirectorExecutivesBiogen Inc.
    2M USD14SEC
    5,450 shares@ US$295.3926.6% of flowCommon StockSEC:0001127602-17-001434:1
  • ◆
    DirectorExecutivesBiogen Inc.
    0SEC
    1,060 shares0Common StockSEC:0001127602-16-055198:0
  • ◆
    DirectorExecutivesBiogen Inc.
    0SEC
    695 shares0Common StockSEC:0001127602-15-020458:0
  • ◇
    DirectorExecutivesBiogen Inc.
    146,844 USD0SEC
    3,125 shares@ US$46.99Common StockSEC:0001127602-15-011048:0
  • ▼
    DirectorExecutivesBiogen Inc.
    82,122 USD0SEC
    200 shares@ US$410.61Common StockSEC:0001127602-15-011048:1
  • ▼
    DirectorExecutivesBiogen Inc.
    123,438 USD0SEC
    300 shares@ US$411.46Common StockSEC:0001127602-15-011048:2
  • ▼
    DirectorExecutivesBiogen Inc.
    289,079 USD0SEC
    700 shares@ US$412.97Common StockSEC:0001127602-15-011048:3
  • ▼
    DirectorExecutivesBiogen Inc.
    413,990 USD0SEC
    1,000 shares@ US$413.99Common StockSEC:0001127602-15-011048:4
  • ▼
    DirectorExecutivesBiogen Inc.
    124,542 USD0SEC
    300 shares@ US$415.14Common StockSEC:0001127602-15-011048:5
  • ▼
    DirectorExecutivesBiogen Inc.
    218,531 USD0SEC
    525 shares@ US$416.25Common StockSEC:0001127602-15-011048:6
  • ▼
    DirectorExecutivesBiogen Inc.
    41,727 USD0SEC
    100 shares@ US$417.27Common StockSEC:0001127602-15-011048:7
  • ◇
    DirectorExecutivesBiogen Inc.
    26,110 USD0SEC
    500 shares@ US$52.22Common StockSEC:0001127602-15-011048:8
  • ▼
    DirectorExecutivesBiogen Inc.
    164,024 USD0SEC
    400 shares@ US$410.06Common StockSEC:0001127602-15-011048:9
  • ▼
    DirectorExecutivesBiogen Inc.
    41,133 USD0SEC
    100 shares@ US$411.33Common StockSEC:0001127602-15-011048:10
  • ◆
    DirectorExecutivesBiogen Inc.
    0SEC
    870 shares0Common StockSEC:0001127602-14-020910:0
  • ◇
    DirectorExecutivesBiogen Inc.
    297,188 USD0SEC
    6,250 shares@ US$47.55Common StockSEC:0001127602-14-013561:0

25 of 145 declarations